Molecular Formula | C5H6INO |
Molar Mass | 223.01 |
Density | 1.8763 (estimate) |
Melting Point | 51 °C |
Boling Point | 239.2±35.0 °C(Predicted) |
Flash Point | 98.5°C |
Solubility | soluble in Methanol |
Vapor Presure | 0.0628mmHg at 25°C |
Appearance | Pale yellow powder |
Color | Light yellow to Yellow to Orange |
pKa | -2.30±0.28(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Sensitive | Light Sensitive |
Refractive Index | 1.566 |
MDL | MFCD00173743 |
Risk Codes | 41 - Risk of serious damage to eyes |
Safety Description | S24/25 - Avoid contact with skin and eyes. S39 - Wear eye / face protection. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
HS Code | 29349990 |
Hazard Class | LIGHT SENSITIVE |
Introduction | 3, 5-dimethyl-4-iodoisoxazole is an organic intermediate, which can be obtained by 3, 5-dimethylisoxazole iodide. |
Uses | 3, 5-dimethylisoxazole is a heterocyclic organic compound, which can be used to prepare α4β1 and α4β7 antagonists. |
Preparation | Triethyl germanium chloride (1.05 equivalents) and the corresponding aryl iodide or aryl bromide (1.0 equivalents) are dissolved in anhydrous and degasified THF(0.2 M) under argon. Add iPrMgCl(1.2 M in THF; 1.2 equivalents) slowly to the reaction mixture. The reaction mixture was stirred at room temperature for 3 hours. Quenching the reaction mixture by adding NH4Cl (saturated) aqueous solution. Separation of the organic phase. The aqueous phase was extracted with DCM (3x). The combined organic phase was dried with magnesium sulfate. Remove the solvent under reduced pressure. The crude mixture was purified by silica gel column chromatography (DCM) to obtain 3, 5-dimethyl-4-iodoisoxazole. |